The ultimate nanovehicle - engineer exosomes for custom cargo delivery shuttles into target cells. Cargoes include nucleic acid and even small molecules. Continue reading →

Present in a wide variety of body fluids - including the easily accessible urine, plasma, and saliva - and loaded with cargoes of general and unique nucleic acid, protein, and lipids, exosomes provide an exciting opportunity for the discovery of disease biomarkers. Continue reading →

A number of different biochemical and biophysical techniques can be used to verify that your preparation contains exosomes, and to quantify the amount of exosomes you have isolated. Continue reading →

SBI’s lentiviral reagents and miR services help researchers bridge the gap between GWAS and phenotype at a QTL involved in hematopoiesis and acute myeloid leukemia. Continue reading →

PRESS RELEASE: System Biosciences (SBI), a leading provider of exosome research tools and services, Continue reading →

A roundup of the recent exosome literature highlights the therapeutic potential of stem cell-derived exosomes and the complex role of exosomes in cancer. Continue reading →

SBI offers hands-on and custom on-line/in-person opportunities to learn more about exosomes and stay up-to-date with the latest advances. Continue reading →

SBI’s Exo-NGS Service drives discoveries and fuels insights into glioblastoma heterogeneity and, thus, pathogenicity. Continue reading →

System Biosciences pGreenFire Reporter Vectors fuel antiviral drug discovery and the search for robust, broad-spectrum antiviral agents. Continue reading →

SBI works with scientists to commercialize their technologies through licensing and other programs. Continue reading →